EXPERIMENTAL SYMPATHETIC ACTIVATION CAUSES ENDOTHELIAL INJURY IN THE RABBIT THORACIC AORTA VIA BETA-1-ADRENOCEPTOR ACTIVATION

被引:79
作者
PETTERSSON, K
BEJNE, B
BJORK, H
STRAWN, WB
BONDJERS, G
机构
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT COMPARAT MED,WINSTON SALEM,NC 27103
[2] SAHLGRENS UNIV HOSP,WALLENBERG LAB,S-41345 GOTHENBURG,SWEDEN
关键词
Endothelial injury; Rabbits; Sympathetic activation; β-Antagonists; β[!sub]1[!/sub]-Adrenoceptors;
D O I
10.1161/01.RES.67.4.1027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sympathetic activation appears to accelerate the development of atherosclerosis, an effect that may be inhibited by β-receptor blockade. It is unclear, however, which mechanisms mediate this effect. In view of the significance attached to endothelial injury in the initial phases of atherogenesis, we decided to test whether sympathetic activation might lead to an increase in endothelial injury. Chloralose anesthesia was used to induce sympathetic activation and the presence of intracellular IgG as a criterion of endothelial cell injury. The β1-selective β-blocker metoprolol was used to evaluate if the effect(s) of sympathetic activation might be mediated by β1-adrenoceptors. In normal rabbits, the frequency of injured endothelial cells in unbranched areas of the thoracic aorta was 0.23%, compared with 1.93% in circumostial areas. Chloralose anesthesia caused significant increases in blood pressure, heart rate, and plasma norepinephrine, that is, caused sympathetic activation, and led to an approximately fivefold increase in the number of injured cells both in unbranched and in circumostial areas. This increase was totally inhibited by metoprolol pretreatment, indicating that it was mediated by β1-receptors. These observations suggest one possible mechanism that may connect sympathetic activation with atherogenesis and explain why β-blockade protects against atherosclerosis.
引用
收藏
页码:1027 / 1034
页数:8
相关论文
共 44 条
[1]   THE ROLE OF SYMPATHETIC ACTIVITY IN ATHEROGENESIS - EFFECTS OF BETA-BLOCKADE [J].
ABLAD, B ;
BJORKMAN, JA ;
GUSTAFSSON, D ;
HANSSON, G ;
OSTLUNDLINDQVIST, AM ;
PETTERSSON, K .
AMERICAN HEART JOURNAL, 1988, 116 (01) :322-327
[2]   RETARDING EFFECT OF LOWERED HEART-RATE ON CORONARY ATHEROSCLEROSIS [J].
BEERE, PA ;
GLAGOV, S ;
ZARINS, CK .
SCIENCE, 1984, 226 (4671) :180-182
[3]   ENDOTHELIAL INTEGRITY AND VIABILITY IN AORTA OF NORMAL RABBIT AND RAT AS EVALUATED WITH DYE EXCLUSION TESTS AND INTERFERENCE CONTRAST MICROSCOPY [J].
BJORKERUD, S ;
BONDJERS, G .
ATHEROSCLEROSIS, 1972, 15 (03) :285-+
[4]  
BJORKERUD S, 1981, STRUCTURE FUNCTION C, V3, P211
[5]  
BONDJERS G, 1977, ARTERY, V3, P395
[6]   THE BETA-RECEPTOR, ATHEROMA AND CARDIOVASCULAR DAMAGE [J].
CRUICKSHANK, JM ;
SMITH, JC .
PHARMACOLOGY & THERAPEUTICS, 1989, 42 (03) :385-404
[7]   A PERSPECTIVE ON TYPE-A BEHAVIOR AND CORONARY-DISEASE [J].
DIMSDALE, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (02) :110-112
[8]  
ERIKSSON BM, 1981, CLIN CHEM, V27, P341
[9]   DETERMINATION OF METOPROLOL IN PLASMA AND URINE USING HIGH-RESOLUTION GAS-CHROMATOGRAPHY AND ELECTRON-CAPTURE DETECTION [J].
ERVIK, M ;
KYLBERGHANSSEN, K ;
JOHANSSON, L .
JOURNAL OF CHROMATOGRAPHY, 1986, 381 (01) :168-174
[10]  
FRIEDMAN M, 1974, TYPE A BEHAVIOR YOUR